10 Best Tech Stocks to Buy According to Billionaires
As AI reshapes the global economy, billionaire investors and prominent fund managers are placing bold bets on the next wave of tech winners.
Author Archive - Rizwan Siddiqui
BofA Still Sees Trouble on the Road for Lyft (LYFT)
On June 4, Bank of America Securities analyst Mike McGovern reiterated a Sell rating on Lyft Inc. (NASDAQ:LYFT), with an unchanged price target of $12.
Toyota Industries’ (TYIDF) Privatization Plan Met with Scrutiny Over Valuation
On June 4, Bloomberg reported that the Toyota Group has announced a ¥4.7 trillion ($33 billion) plan to take Toyota Industries Corporation (OTC:TYIDF) private.
Wells Fargo Turns More Bullish on Ferguson (FERG), Raises TP
On June 4, Wells Fargo analyst Sam Reid reiterated a Buy rating on Ferguson Enterprises Inc. (NYSE:FERG), while raising the price target from $190 to $230.
Wells Fargo’s (WFC) Growth Engine Restarts with Fed’s Asset Cap Removal
On June 4, the Federal Reserve lifted the long-standing asset cap on Wells Fargo & Company (NYSE:WFC), signaling a significant turning point for the bank after more than seven...
Reddit (RDDT) Says Anthropic Scraped Too Deep, Files Lawsuit
On Wednesday, June 4, Bloomberg reported that Reddit Inc.
Wells Fargo Sees No Fizz in PepsiCo (PEP) Amid Profitability Concerns
On June 4, Wells Fargo analyst Christopher Carey maintained a Hold rating on PepsiCo Inc.
Jefferies Maintains Buy Rating on Gilead Sciences (GILD), Cites Robust Pipeline
On June 4, Jefferies analyst Michael Yee reaffirmed a Buy rating on Gilead Sciences Inc. (NASDAQ:GILD), maintaining his price target at $130.
Wells Fargo Reaffirms Buy Rating on Moody’s (MCO) With $572 PT
On June 4, Wells Fargo analyst Jason Haas reaffirmed his Buy rating on Moody’s Corporation (NYSE:MCO) with a price target of $572.
Jefferies Sees Upside in Uber (UBER) from Market Expansion, Reiterates Buy Rating
On June 4, Jefferies analyst John Colantuoni maintained a Buy rating on Uber Technologies Inc. (NYSE:UBER) with a price target of $100.
Kimberly-Clark (KMB) Set to Divest Global Tissue Unit to Refocus Portfolio
According to the Wall Street Journal (WSJ), Kimberly-Clark Corp.
BMO Capital Maintains Buy Rating on Corpay (CPAY), Keeps PT
On June 3, BMO Capital’s analyst Rufus Hone reiterated a Buy rating on Corpay Inc. (NYSE:CPAY), with an unchanged price target of $410.
Needham Says Promising Data Underscore Growth Potential for Jazz Pharma (JAZZ)
On June 3, Needham analyst Ami Fadia reaffirmed a Buy rating on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) and raised the price target slightly from $200 to $202.
BMO Maintains Hold on BridgeBio (BBIO) Amid Intensifying Competition
On June 3, BMO Capital Markets analyst Kostas Biliouris reiterated a Hold rating on BridgeBio Pharma Inc. (NASDAQ:BBIO) with an unchanged price target of $37.
Jefferies Thinks Lululemon’s (LULU) Growth Story Remains Under Strain, Maintains Sell Rating
On June 3, Jefferies analyst Randal Konik reiterated a Sell rating on Lululemon Athletica Inc. (NASDAQ:LULU) and maintained his price target of $220.
Needham Downgrades Apple (AAPL), Flags $170–$180 as Attractive Entry Level
On Wednesday, Needham analyst Laura Martin downgraded Apple Inc. (NASDAQ:AAPL) to Hold from Buy without assigning any price target.
Chart Industries (GTLS) and Flowserve to Merge in $19 Billion All-Stock Deal
On Wednesday, Chart Industries Inc.
Goldman Sees Strong Utility Tailwinds for Quanta (PWR), Hikes Price Target to $414
On June 3, Goldman Sachs analyst Atidrip Modak raised the price target on Quanta Services Inc. (NYSE:PWR) from $364 to $414, while maintaining a Buy rating.
Bernstein Initiates Coverage of Spotify (SPOT) With an Outperform Rating
On June 3, Bernstein analyst Ian Moore initiated coverage on Spotify Technology S.A. (NYSE:SPOT) with an Outperform rating and assigned a price target of $825.
Truist Sticks to $35 Target on Summit (SMMT) Despite Shifting Deal Landscape
In a June 2 report, Truist Securities analyst Asthika Goonewardene weighed in on the implications of Bristol-Myers Squibb’s newly announced partnership with BioNTech SE on Summit...
KKR (KKR) Sweetens Offer Terms for Datagroup as Acquisition Process Advances
On June 2, Reuters reported that, in a development related to KKR & Co.
Barclays Downgrades Centene (CNC) on Policy Risk, Cuts Price Target to $65
The downgrade follows Centene’s first-quarter results and concerns about its exposure to Medicare Part D* and Affordable Care Act (ACA) markets.
Bernstein Downgrades Charter (CHTR) to Market Perform on Valuation
On June 2, Bernstein analyst Laurent Yoon downgraded Charter Communications Inc.
Morgan Stanley Stays Bearish on FedEx Ahead of Q4 Results
On Monday, June 2, Morgan Stanley analyst Ravi Shanker reiterated a Sell rating on FedEx Corp. (NYSE:FDX), maintaining his $200 price target.
BofA Remains Optimistic on Warner Bros. Discovery’s (WBD) Improved Strategic Flexibility
While the company’s stock has underperformed since the merger of Discovery and WarnerMedia in early 2022, Ehrlich believes Warner Bros.
Truist initiates Toast (TOST) with a Buy Rating and $48 Price Target
On June 2, Truist Securities analyst Matthew Coad initiated coverage on Toast Inc.
Zscaler’s (ZS) Growth Momentum Intact, Says Robert Baird
On June 2, Shrenik Kothari of Robert W. Baird reiterated his Buy rating on Zscaler Inc. (NASDAQ:ZS) with an unchanged price target of $315.
Alnylam Pharmaceuticals (ALNY) Price Target Raised to $500 by H.C. Wainwright
On June 2, H.C. Wainwright’s Patrick Trucchio reiterated his Buy rating on Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) and raised his price target from $400 to $500.
Needham Reaffirms Bullish View on Applied Digital (APLD) Following Landmark Ellendale Lease
On Monday, June 2, Needham’s John Todaro reaffirmed his Buy rating on Applied Digital Corporation (NASDAQ:APLD), keeping the price target unchanged at $10.
Morgan Stanley Lifts Grab (GRAB) Price Target, Maintains Buy Rating
On June 2, Morgan Stanley’s Divya Gangahar Kothiyal reiterated a Buy rating on Grab Holdings Limited (NASDAQ:GRAB) while revising the price target upward from $5.20 to $5.65...
TSMC (TSMC) Eyeing Middle East Expansion but Geopolitical Hurdles Abound
According to a May 30 report from Bloomberg, Taiwan Semiconductor Manufacturing Company (NYSE:TSM) is evaluating the potential for establishing an advanced semiconductor manufacturing...
Morgan Stanley Remains Bullish on Axsome (AXSM), Reiterates $190 PT
Purohit’s continued optimism is primarily driven by the strong commercial performance of Auvelity, the company’s treatment for major depressive disorder (MDD).
JP Morgan Boosts Zscaler’s (ZS) Price Target to $292, Maintains Buy Rating
On May 30, JP Morgan’s Brian Essex reiterated his Buy rating on Zscaler Inc. (NASDAQ:ZS) and raised the stock’s price target from $275 to $292.
Regeneron (REGN) Downgraded at RBC Capital, Price Target Cut Sharply
On May 30, RBC Capital analyst Brian Abrahams downgraded Regeneron Pharmaceuticals Inc.
Bristol-Myers (BMY) Licenses BioNTech’s Immunotherapy in $11 billion Deal
On Monday, June 2, Bloomberg reported that Bristol-Myers Squibb Company (NYSE:BMY) and BioNTech SE (NASDAQ:BNTX) announced a strategic licensing agreement focused on next-generation...
Moderna (MRNA) Faces Multiple Regulatory Challenges
On May 31, Bloomberg reported that the FDA recently granted Moderna Inc. (NASDAQ:MRNA) a narrower approval for its next-generation COVID-19 vaccine.
Morgan Stanley Maintains Hold on EchoStar (SATS) Amid Regulatory Uncertainty
On May 30, Morgan Stanley analyst Benjamin Swinburne reiterated a Hold rating on EchoStar Corporation (NASDAQ:SATS), with an unchanged price target of $25.
BofA Maintains Underperform on UiPath (PATH) Despite Improved Q1 Execution
On May 30, Bank of America Securities analyst Bradley Sills raised his price target on UiPath Inc.
Goldman Lifts Costco (COST) Price Target After Steady Q3 Results
Following Costco Wholesale Corp.’s (NASDAQ:COST) Q3 FY 2025 earnings results, a Goldman Sachs analyst reiterated a Buy rating on the stock and slightly raised the price target...
Goldman Sees Limited Downside in Alphabet (GOOGL)
On May 30, a Goldman Sachs analyst reiterated a bullish stance on Alphabet Inc. (NASDAQ:GOOGL), maintaining a Buy rating and a $220 price target.
Citi Resumes Coverage of Kellanova (K) with Neutral Rating
The analyst highlighted concerns about the company’s pending acquisition, which he views as a critical driver of the current stock valuation.
BofA Maintains Buy Rating on Motorola (MSI), Keeps $520 PT
Following Motorola Solutions Inc.’s (NYSE:MSI) acquisition of Silvus Technologies Inc., Bank of America Securities analyst Tomer Zilberman reiterated a Buy rating and maintained...
Goldman Sachs Initiates Coverage of DexCom (DXCM) With Buy Rating
DexCom, a global leader in glucose biosensing systems, stands out for its innovative continuous glucose monitoring (CGM) technology.
Coherent (COHR) Earns Buy from Benchmark on Growth Momentum
On May 29, Mark Miller of Benchmark Company reiterated a Buy rating on Coherent Corp. (NYSE:COHR), with an unchanged price target of $95.
SentinelOne (S) Downgraded by BofA on Growth Concerns, Target Price Trimmed
Tal Liani of Bank of America Securities has downgraded SentinelOne Inc.
Morgan Stanley Remains Bullish on Progressive (PGR) Citing Underwriting Strength
Bob Huang, an analyst from Morgan Stanley, reiterated his Buy rating on The Progressive Corporation (NYSE:PGR), maintaining a price target of $330, on May 29.
Wells Fargo Upgrades HCA Healthcare (HCA) As Risks Appear Priced In
On May 29, an analyst from Wells Fargo upgraded HCA Healthcare Inc.
Synopsys (SNPS) Moves Ahead in Ansys Merger After FTC Divestiture Order
The Federal Trade Commission (FTC) issued a divestiture order on May 28, requiring Synopsys Inc. (NASDAQ:SNPS) and Ansys Inc.
BofA Cuts PDD Holdings (PDD) Target to $120, Maintains Hold
On May 28, PDD Holdings (NASDAQ:PDD) reported weaker quarterly results, prompting Bank of America Securities analyst Joyce Ju to lower her price target to $120 from $140 and reiterate...
Synopsys (SNPS) Halts Guidance After BIS China Export Notice
On May 29, Synopsys Inc.
